icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
 Back grey_arrow_rt.gif
 
 
 
Bulevirtide Monotherapy Is Safe and Well Tolerated in Patients With Chronic Hepatitis D (CHD): An Integrated Safety Analysis of 48-Week Data
 
 
  AASLD 2022 Nov 4-8 Wash DC

1108221

1108222

1108223

1108224

1108225

1108226